BE Board:Industrial seminar series: Difference between revisions
No edit summary |
Barry Canton (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{Template:BE Board}} | {{Template:BE Board}} | ||
<div style="padding: 10px; width: 720px; border: 5px solid #2D9258;"> | |||
==Upcoming Speakers== | ==Upcoming Speakers== | ||
| Line 83: | Line 80: | ||
"After the PhD: Career decisions in biomedical engineering" | "After the PhD: Career decisions in biomedical engineering" | ||
</div> | </div> | ||
Latest revision as of 07:26, 6 December 2005
For current website see begradboard.mit.edu
Upcoming Speakers
September 23, 2005 - * Special Bioethics Seminar * Stempsey (College of Holy Cross)
October 28, 2005 - * Special Bioethics Seminar * Thomas Shannon (Worcester Polytechnic Institute)
December 2, 2005 Mark Trusheim (Massachusetts Biotechnology Council) - 56-114 1:30 - 2:30 pm
Past Speakers
- July 22, 2005
Dr. Paul Mason (Genzyme) "Drug discovery at Genzyme"
- June 10, 2005
Dr. Gyan Bhanot (IBM Life Sciences) "Systems biology and supercomputing at IBM Life Sciences"
- May 20 , 2005
Dr. Damon Demady (Biogen Idec) "Challenges of drug development: By the book vs. reality"
- April 22, 2005
Dr. Jinping Gan (Bristol-Myers Squibb) "Reactive metabolites in drug discovery"
- April 15, 2005
John Essigmann (MIT BE & CEHS) "De-mystification of the grant application process for new academic investigators"
- April 8, 2005
Nancy Briefs (President & CEO of Percardia) "A long winding road: From patent to PMA"
- March 25, 2005
Dr. Can Ozbal (BioTrove Inc.) "Mass spectroscopy-based label-free ultra-high throughput screening for drug discovery"
- March 11, 2005
Dr. Jonathan Gertler (Adams Harkness) "Market dynamics & financial strategies in life science technologies"
- February 25, 2005
Dr. Cindy Xia (Millenium) "From ABC to SLC: Evaluation of drug transporters in drug discovery and development"
- February 11, 2005
Dr. Keith Hoffmaster (Pfizer Inc.) "ADME in drug discovery & cholestasis as a mechanism of hepatotoxicity"
- December 13 , 2004
Drs. Birgit Schoeberl & Brian Harms (Merrimack Pharmaceuticals Inc.) "Starting a career in industry as an MIT alum"
- November 22, 2004
Dr. Vicki Sato (President of Vertex Pharmaceuticals Inc.) "Careers in academia & in industry"
- October 5, 2004 (see picture :))
Prof. Michael Lysaght (Brown University) "After the PhD: Career decisions in biomedical engineering"
